Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with...
Freshfields advised Agilent (NYSE: A) on its acquisition of Resolution Bioscience. The combination brings together Resolution Bioscience’s noninvasive liquid biopsy platform that improves cancer diagnostics with...
